CollPlant Biotechnologies (CLGN) Shareholder's Equity (2017 - 2026)

CollPlant Biotechnologies (CLGN) Shareholder's Equity (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 7.14 Bn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 795.79 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 595,226.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 14.38 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.37 Bn 94.37 Bn - 502.95 Mn
10 CollPlant Biotechnologies 7.20 Mn 7.20 Mn - 4.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.89 Mn
Dec 31, 2025 6.08 Mn
Sep 30, 2025 9.31 Mn
Jun 30, 2025 12.51 Mn
Mar 31, 2025 12.40 Mn
Dec 31, 2024 13.47 Mn
Sep 30, 2024 16.92 Mn
Jun 30, 2024 20.73 Mn
Mar 31, 2024 24.45 Mn
Dec 31, 2023 28.34 Mn
Sep 30, 2023 32.40 Mn
Jun 30, 2023 36.04 Mn
Mar 31, 2023 29.89 Mn
Dec 31, 2022 32.28 Mn
Sep 30, 2022 35.81 Mn
Jun 30, 2022 39.51 Mn
Mar 31, 2022 43.20 Mn
Dec 31, 2021 45.12 Mn
Sep 30, 2021 48.48 Mn
Jun 30, 2021 49.44 Mn